262 related articles for article (PubMed ID: 26354244)
1. Nanoparticles incorporating pH-responsive surfactants as a viable approach to improve the intracellular drug delivery.
Nogueira DR; Scheeren LE; Pilar Vinardell M; Mitjans M; Rosa Infante M; Rolim CM
Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():100-6. PubMed ID: 26354244
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
[TBL] [Abstract][Full Text] [Related]
3. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
4. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
[TBL] [Abstract][Full Text] [Related]
5. The role of counterions in the membrane-disruptive properties of pH-sensitive lysine-based surfactants.
Nogueira DR; Mitjans M; Infante MR; Vinardell MP
Acta Biomater; 2011 Jul; 7(7):2846-56. PubMed ID: 21421083
[TBL] [Abstract][Full Text] [Related]
6. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
[TBL] [Abstract][Full Text] [Related]
7. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.
Raja MA; Arif M; Feng C; Zeenat S; Liu CG
J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery.
Özbaş-Turan S; Akbuğa J
Drug Deliv; 2011 Apr; 18(3):215-22. PubMed ID: 21226549
[TBL] [Abstract][Full Text] [Related]
11. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery.
Gan Q; Wang T; Cochrane C; McCarron P
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):65-73. PubMed ID: 16024239
[TBL] [Abstract][Full Text] [Related]
12. Monodisperse chitosan nanoparticles for mucosal drug delivery.
Zhang H; Oh M; Allen C; Kumacheva E
Biomacromolecules; 2004; 5(6):2461-8. PubMed ID: 15530064
[TBL] [Abstract][Full Text] [Related]
13. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
Lin AH; Liu YM; Ping QN
Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
[TBL] [Abstract][Full Text] [Related]
14. pH-Sensitive chitosan-tripolyphosphate nanoparticles increase doxorubicin-induced growth inhibition of cervical HeLa tumor cells by apoptosis and cell cycle modulation.
Nogueira-Librelotto DR; Scheeren LE; Macedo LB; Vinardell MP; Rolim CMB
Colloids Surf B Biointerfaces; 2020 Jun; 190():110897. PubMed ID: 32126359
[TBL] [Abstract][Full Text] [Related]
15. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
16. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
[TBL] [Abstract][Full Text] [Related]
17. General Reagent Free Route to pH Responsive Polyacryloyl Hydrazide Capped Metal Nanogels for Synergistic Anticancer Therapeutics.
Ujjwal RR; Purohit MP; Patnaik S; Ojha U
ACS Appl Mater Interfaces; 2015 Jun; 7(21):11497-507. PubMed ID: 25961335
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-tripolyphosphate nanoparticles: Optimization of formulation parameters for improving process yield at a novel pH using artificial neural networks.
Hashad RA; Ishak RA; Fahmy S; Mansour S; Geneidi AS
Int J Biol Macromol; 2016 May; 86():50-8. PubMed ID: 26783636
[TBL] [Abstract][Full Text] [Related]
19. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
[TBL] [Abstract][Full Text] [Related]
20. Chitosan/sodium tripolyphosphate nanoparticles: preparation, characterization and application as drug carrier.
Yang W; Fu J; Wang T; He N
J Biomed Nanotechnol; 2009 Oct; 5(5):591-5. PubMed ID: 20201437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]